Does a new ultrasound probe change the complication rates of transrectal ultrasound-guided needle biopsies of the prostate?

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 3071-3076

  Ecke, Thorsten H ^a   Gerullis, Holger ^b,c   Heuck, Christoph J ^d   Bartel, Peter ^a   Hallmann, Steffen ^a   Koch, Stefan ^a   Ruttloff, Jürgen ^a  

^a HELIOS Klinikum Bad Saarow   (Germany)

^b Lukaskrankenhaus GmbH   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d ALBERT EINSTEIN CANCER CENTER   (United States)

Author keywords

Biopsy; Bleeding; Postoperative complications; Prostate; Ultrasound probe

Indexed keywords

CIPROFLOXACIN; GENTAMICIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLEEDING; CANCER DIAGNOSIS; CANCER PATIENT; CONTROLLED STUDY; DIAPHORESIS; DIGITAL RECTAL EXAMINATION; DRUG WITHDRAWAL; DYSURIA; FEVER; HEMATURIA; HEMOSPERMIA; HUMAN; HUMAN TISSUE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEEDLE BIOPSY; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUESTIONNAIRE; TELEPHONE; TRANSRECTAL ULTRASONOGRAPHY; URINE RETENTION;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY;

EID: 77955807459     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Astraldi A: Diagnosis of cancer of the prostate; biopsy by rectal route. Urol Cutan Rev 41: 421-427, 1937.
2. Hodge KK, McNeal JE, Terris MK and Stamey TA: Random systematic versus directed ultrasound guided transrectal biopsies of the prostate. J Urol 142: 71-74, 1989.
3. Naughton CK, Smith DS, Humphrey PA, Catalona WJ and Keetch DW: Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study. Urology 52: 808-813, 1998.
4. Levine MA, Ittman M, Melamed J and Lepor H: Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 159: 471-475, 1998.
5. Stricker HJ, Ruddock LJ, Wan J and Belville WD: Detection of non-palpable prostate cancer. A mathematical and laboratory model. Br J Urol 71: 43-46, 1993. (Pubitemid 23031113)
6. Coplen DE, Andriole GL, Yuan JJ and Catalona WJ: The ability of systematic transrectal ultrasound guided biopsy to detect prostate cancer in men with the clinical diagnosis of benign prostatic hyperplasia. J Urol 146: 75-77, 1991.
7. Cooner WH, Mosley BR, Rutherford CL Jr, Beard JH, Pond HS, Bass RB Jr and Terry WJ: Clinical application of transrectal ultrasonography and prostate-specific antigen in the search of prostate cancer. J Urol 139(4): 758-761, 1988.
8. Cooner WH, Mosley BR, Rutherford CL Jr, Beard JH, Pond HS Terry WJ, Igel TC and Kidd DD: Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate-specific antigen. J Urol 143(6): 1146-52, 1990.
9. Hodge KK, McNeal JE and Stamey TA: Ultrasound-guided transrectal core biopsies of the palpably abnormal prostate. J Urol 142: 66-70, 1989. (Pubitemid 19184005)
10. Ostroff EB, Almario J and Kramer H: Transrectal needle method for biopsy of the prostate: review of 90 cases. Am Surg 41: 659-661, 1975.
11. Crawford ED, Haynes AL Jr., Story MW and Borden TA: Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol 127(3): 449-451, 1982.
12. Gustafsson O, Norming U, Nyman CR and Ohstrom M: Complications following combined treansrectal aspiration and core biopsy of the prostate. Scand J Urol Nephrol 24: 249-251, 1990. (Pubitemid 20379730)
13. Thompson PM, Talbot RW, Packham DA and Dulake C: Transrectal biopsy of the prostate and bacteraemia. Br J Surg 67(2): 127-128, 1980.
14. Thompson PM, Pryor JP, Williams JP, Eyers DE, Dulake C, Scully MF and Kakkar W: The problem of infection after prostatic biopsy: the case for the transperineal approach. Br J Urol 54(6): 736-740, 1982.
15. Partin AW and Oesterling JE: Clinical use of prostatic-specific antigen: update 1994. J Urol 152: 1358-1368, 1994.
16. Ploch NR and Brawer MK: How to use prostate-specific antigen. Urology 43(2 Suppl): 27-35, 1994.
17. Hudson MA, Bahnson RR and Catalona WJ: Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 142: 1011-1107, 1989.
18. Stamey TA, Yang N, Hay AR, Mc Neal JE, Freiha FS and Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916, 1987. (Pubitemid 17147932)
19. Aus G, Ahlgren G, Bergdahl S and Hugosson J: Infection after transrectal core biopsies of the prostate risk factors and antibiotic prophylaxis. Br J Urol 77(6): 851-855, 1996. (Pubitemid 27407594)
20. Aus G, Hermansson CG, Hugosson J and Pedersen KV: Transrectal ultrasound examination of the prostate: complications and acceptance by patients. Br J Urol 71(4): 457-9, 1993.
21. Sieber PR, Rommel FM, Agusta VE, Breslin JA, Huffnagle HW and Harpster LE: Antibiotic prophylaxis in ultrasound-guided transrectal prostate biopsy. J Urol 157: 2199-2200, 1997. (Pubitemid 27208670)
22. Paul R, Korzinek C, Necknig U, Niesel T, Alschibaja M, Leyh H and Hartung R: Influence of transrectal ultrasound probe on prostate cancer detection in ultrasound-guided sextant biopsy of prostate. Urology 64(3): 532-536, 2004. (Pubitemid 39200752)
23. Ching CB, Moussa AS, Li J, Lane BR, Zippe C and Jones JS: Does transrectal ultrasound probe configuration really matter? End-fire versus side-fire probe prostate cancer detection rates. J Urol 181(5): 2077-2082, 2009.
24. Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF and Schrder FH: Complication rate and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60(5): 826-830, 2002. (Pubitemid 35300348)
25. Rodriguez LV and Terris MK: Risks and complications of transrectal ultrasound-guided prostate needle biopsy: a prospective study and review of the literature. J Urol 160: 2115-20, 1998.
26. Deliveliotis C, John V, Louras G, Andreas S, Alargof E, Sofras F and Goulandris N: Multiple transrectal ultrasound-guided prostatic biopsies: morbidity and tolerance. Int Urol Nephrol 31: 681-686, 1999. (Pubitemid 30179125)
27. Djavan B, Waldert M, Zlotta A, Dobronski P, Seitz C, Remzi M, Borkowski A, Schulman C and Marberger M: Safety and morbidity of first and repeat transrectal ultrasound-guided prostate needle biopsies: Results of a prospective European prostate cancer detection study. J Urol 166: 856-860, 2001.
28. Enlund AL and Varenhorst E: Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic therapy: a prospective study in 415 cases. Br J Urol 70: 777-780, 1997.
29. Manseck A, Guhr K, Froehner M, Hakenberg OW and Wirth MP: Morbidity and discomfort of ten-core biopsy of the prostate evaluated by questionnaire. Urol Int 66: 197-200, 2001. (Pubitemid 32511117)
30. Peyromaure M, Ravery V, Messas A, Toublanc M, Boccon-Gibod L and Boccon-Gibod L: Pain and morbidity of an extensive prostate 10-biopsy protocol: a prospective study in 289 patients. J Urol 167: 218-21, 2002. (Pubitemid 34024536)
31. Rietbergen JB, Kruger AE, Kranse R and Schröder FH: Complications of transrectal ultrasound (TRUS)-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology 49: 875-880, 1997. (Pubitemid 27246956)
32. Ecke TH, Gunia S, Bartel P, Hallmann S, Koch S and Ruttloff J: Complications and risk factors of transrectal ultrasound-guided needle biopsies of the prostate evaluated by questionnaire. Urol Oncol 26(5): 474-478, 2008.
33. Ashby EC, Rees M and Dowding CH: Prophylaxis against systemic infection after transrectal biopsy for suspected prostatic carcinoma. Br Med J 2: 1263-1264, 1978. (Pubitemid 9044960)
34. Davison P and Malament M: Urinary contamination as a result of transrectal biopsy of the prostate. J Urol 105(4): 545-546, 1971.
35. Fawcett DP, Eykyn S and Bultitude MI: Urinary tract infection following transrectal biopsiy of the prostate. Br J Urol 47(6): 679-81, 1975.
36. Vallancien G, Prapotnich D, Veillon B, Brisset JM and Andre-Bougaran J: Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 146(5): 1308-1312, 1991.
37. Breslin JA, Turner BI, Faber RB and Rhamy RK: Anaerobic infection as a consequence of transrectal prostatic biopsy. J Urol 120: 502-503, 1978. (Pubitemid 9031124)
38. Norberg M, Holmberg L, Haggman M and Magnusson A: Determinants of complications after multiple transrectal core biopsies of the prostate. Eur Radiol 6: 457-461, 1996. (Pubitemid 126462804)
39. Irani J, Fournier F, Bon D, Gremmo E, Dore B and Aubert J: Patients tolerance of transrectal ultrasound-guided biopsiy of the prostate. Br J Urol 79: 608-610, 1997. (Pubitemid 28321106)
40. Clements R, Aideyan OU, Griffiths GJ and Peeling WB: Side effects and patient acceptability of transrectal biopsy of the prostate. Clin Radiol 47: 125-126, 1993. (Pubitemid 23077828)